Fewer Prescribers Are Driving NBRx Than You Think—Here’s Why
PM360
AUGUST 9, 2022
By 2020, that percentage plummeted to just 8%. While it’s unsurprising that patients flock to these cheaper alternatives to treat common conditions, generic medications aren’t as accessible for specialized conditions, which gives pharma marketers an opportunity to drive scripts where the market is less crowded.
Let's personalize your content